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ABSTRACT 
The measurement of serum of urinary hCG is com­
monly used to make or exclude the diagnosis of 
ectopic pregnancy in women presenting with symp­
toms suspicious of ectopic pregnancy. Detection of 
depressed hCG levels is indicative ofearly pregnancy 
failure. Depressed serum levels of proteins of hor­
mone oftrophoblastic, ovarian or endometrial origin 
make the diagnosis of ectopic gestation more likely, 
whilst high values are likely to exclude the possibility 
of this condition. 
INTRODUCTION 
Unlike lower animals, implantation in the human species 
can occur in a variety of locations. The incidence of 
ectopic pregnancy has more than doubled in the United 
States from 4.5 to 9.4 per 1000 reported pregnancies 
from 1970 to 1978 (I). Apart from the fetal wastage 
involved, ectopic pregnancy remains the major cause of 
maternal mortality in the first trimester of pregnancy in 
the western world (2). A recent study has shown an 
increased risk of ectopic pregnancy mortality among 
black as compared with white women, and among young 
as compared with old women (3). The poor fertility 
prognosis for women who have had an ectopic preg­
nancy should be emphasised. Less than half will con­
ceive again, and only one-third will bear a live child (4, 
5). The risk of a second ectopic pregnancy is approxi­
mately 8 per cent. Curran (6) has predicted that by the 
year 2000, 10 per cent of all women of reproductive age 
will be sterile because of pelvic inflammatory disease 
(PID), and approximately 3 per cent will have had an 
ectopic pregnancy. These dismal statistics form the basis 
of the rationale for earlier diagnosis and treatment of this 
serious disease. 
DIAGNOSIS OF ECTOPIC PREGNANCY 
In the acute situation; where there is clinical evidence of 
haemoperitoneum, the only diagnostic test required is a 
laparoscopy or occasionally emergency laparotomy. In 
the clinically stable woman with a positive pregnancy 
test complaining of abdominal pain, the diagnosis of 
ectopic pregnancy is aided by a higher index of suspicion 
and a few well chosen diagnostic tests. It is noteworthy 
that the early stages ofectopic pregnancy may mimic the 
symptoms of other gynaecological conditions such as 
PID, ruptured corpus luteum, dysfunctional uterine bleed­
ing and threatened or incomplete abortion (7). Subfertile 
patients who have a past history of ectopic gestation, 
have undergone tubal surgery or attend an in-vitro ferti­
lisation (IVF) or Gamete Intra Fallopian Transfer (GIFT) 
programme are considered at high risk for ectopic preg­
nancy. In having the advantage of intensive clinical, 
biochemical and sonographic monitoring, the diagnosis 
is often made earlier in this group. At present there is no 
effective biochemical measurement which discriminates 
between failed intrauterine pregnancy and ectopic gesta­
tion. This review will summarise current opinion on the 
measurement oftrophoblastic proteins (human chorionic 
gonadotrophin [hCG J, Schwangershaftsprotein 1 [SP I], 
human placental lactogen [hPL] , and pregnancy-associ­
ated plasma protein A [PAPP-AD, endometrial (proges­
terone dependent endometrial protein [PEP]/placental 
protein 14 [PPI4D and decidual proteins (insulin-like 
growth factor binding protein lIGF-BP]/placental pro­
tein 12 [PP 12D, fetal proteins (alphafetoprotein [AFP]), 
and ovarian steroids (oestradiol and progesterone), in the 





hCG estimations remain the mainstay of the differential 
diagnosis of abdominal pain in women of reproductive 
age (8). Although early and fast detection of low levels 
of hCG is important, the efficiency of any given preg­
nancy test based on hCG depends on its sensitivity and 
specificity, which are in turn, a reflection of the sample 
fluid tested and technique used. Urinary latex agglutina­
tion inhibition tests have a sensitivity of 700-1000 IU/I 
and are positive in up to 50 per cent of patients with 
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ectopic gestation (9). Simple dipstick techniques for the 
measurement of hCG based on enzyme labelled 
monoclonal antibodies (10) or immunofluorometric as­
says (11) have been introduced into clinical practice. The 
high sensitivity (lIUII) and speed (10 minutes incuba­
tion time) of these new generation assay techniques have 
contributed greatly to the increased clinical acceptability 
ofthis bedside test. However, it should be noted that very 
low levels of hCG which may result from human pitui­
tary hCG (12) have also been recorded in the serum of 
non-pregnant and postmenopausal women. 
The false negative rate of hCG estimations in patients 
with ectopic pregnancy clearly depends on the cut-off 
level used. Poulsen and colleagues (13) have reported 8 
cases ofectopic pregnancy with un detectable or very low 
levels of circulating hCG «25 lUll) emphasising that a 
high index of suspicion should be maintained if a diag­
nosis of ectopic pregnancy is suspected, even if serum 
hCG is undetectable in the peripheral circulation. Olson 
(14) and Romero and colleagues (15) report false nega­
tive rates for ectopic pregnancy of 0.5 per cent at a 
detection limit of 10 lUll (IRP) [= 5 lUll 2nd IS] and 0 
per cent at <3 lUll. 
Ectopic pregnancies generally produce hCG at a slower 
rate than normal pregnancies (16). Normal hCG values 
are found more often in early and in unruptured ectopic 
pregnancies (17). This has led to the theory that the more 
viable the ectopic pregnancy is, the more likely it is to 
rupture. In addition, negative «25 lUll 2nd IS) hCG 
estimations are associated with marked necrosis of 
chorionic tissue (13), supporting the concept that the 
reduction in functional trophoblast mass is due to poor 
vascularisation and cell necrosis. It has also been sug­
gested that the lower hCG levels in ectopic pregnancy 
may be related to the high incidence of blighted ova (18) 
in this group of pregnancy failure . Indeed, normal hCG 
levels are recorded when normally developed embryos 
are removed from the fallopian tube (19). Individual 
variations in levels of serum hCG are large, such that 
there is a great deal of overlap between normal and 
pathological pregnancies at any given gestational age. 
This suggests that unless the time of conception is known 
with some accuracy, hCG estimations alone are of lim­
ited value in the diagnosis of ectopic pregnancy (20). 
To further improve the diagnostic value ofhCG estima­
tions, some workers have analysed the rate of hCG 
production, correlating it with the sonographic detection 
of a gestational sac. Kadar and colleagues (21) have 
established a discriminatory hCG zone (6000 to 6500 IU / 
I), i.e. the levels of heG at which a gestational sac first 
becomes visible using abdominal ultrasound. By calcu­
lating the doubling rates of hCG they have devised a 
simple algorithm forthe management of suspected ectopic 
pregnancy based on serial quantitative hCG estimations. 
hCG measurements should be performed at 48 hour 
intervals, as after one day there is only a 30 per cent 
increase in the hCG titre, a value which may overlap with 
the level ofan intrauterine pregnancy. After spontaneous 
abortion, the half-life of hCG is reported to be between 
3 and 7 days (22). Thus the information obtained from a 
single hCG estimation may not reflect the actual state of 
the trophoblast. The shorter half-life of the alpha subunit 
ofhCG may make it a better diagnostic test. L'Hermite­
Baleriaux and colleagues (23) have shown that if hCG 
levels are depressed, beta-hCG is less affected than the 
alpha subunit, suggesting that the alpha subunit of hCG 
reflects an early alteration of the trophoblast at a time 
when hCG secretion is still preserved. The 
pathophysiology of these observations is as yet un­
known, but warrants further investigation. 
SCHWANGERSCHAFTSPROTEIN 1 
(SP 1) 
SPl is a glycoprotein with a molecular weight of 90KD. 
It is secreted by the syncytiotrophoblast and appears in 
the maternal circulation shortly after implantation (24). 
SPl measurements have also been evaluated in the 
diagnosis of ectopic pregnancy. Despite encouraging 
initial results (25), the high false-positive rates diminish 
its value in excluding ectopic gestation (26). 
Our own observations in a group of 294 women with a 
subacute presentation of suspected ectopic pregnancy, 
revealed that all but 25 of the 105 women with confirmed 
ectopic pregnancy had normal circulating levels of SPI. 
This would suggest that the synthesis of this protein is 
independent of the site of implantation, thus limiting its 
usefulness in the diagnosis of ectopic pregnancy. Never­
theless, SPl can be used as a pregnancy test in women 
who have received hCG for ovulation induction and 
hence it may retain a limited role in women undergoing 




PROTEIN A (PAPP.A) 

PAPP-A estimations appears to be of greater value than 
other pregnancy proteins in the diagnosis of ectopic 
pregnancy (13, 28-36). Contrary to the findings of the 
first published report (37), several studies have docu­
mented un detectable or depressed PAPP-A levels in 50 
per cent of women with histologically proven ectopic 
pregnancy. By contrast, hCG and SPl were detected in 
almost all patients studied (30). In our own study of 294 
women with suspected ectopic pregnancy, the condition 
was confirmed in 105. Depressed levels of hCG were 
found in all but 15 women, 9 of whom had a live 
extrauterine pregnancy confirmed at ultrasound exami­
nation. By contrast, all but 25 patients had normal 
circulating levels of SPI. Circulating PAPP-A was de­
tected in only 34 women with ectopic pregnancy, of 
whom 24 had levels within the normal range. In the 
remaining women, P APP-A was undetectable by our in­
house radioimmunoassay (RIA) with a detection limit of 
0.02 IU/I. It should be noted, however, that this protein 
cannot be detected at less than 7 weeks gestation, such 
that a negative P APP-A result alone prior to this date 
cannot exclude an ectop!c pregnancy. 
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Immunohistochemical techniques have demonstrated 
the relative paucity of PAPP-A in tubal trophoblastic 
tissue (38), which may be a reflection of either poor 
vascularisation at the ectopic implantation site or a 
selective compromise of PAPP-A synthesis in this con­
dition. The apparently normal distribution of other preg­
nancy proteins and hormones (hCG, hPL, SP 1) in ectopic 
pregnancy as determined by immunohistochemical lo­
calisation studies, would suggest that the controlling 
mechanism for the synthesis of these proteins differs 
from that of P APP-A. In vitro explant studies are in 
progress to investigate the possible mechanisms of re­
duced circulating P APP-A levels in ectopic gestation. 
HUMAN PLACENTAL LACTOGEN (hPL) 
This placental hormone with a molecular weight of 
25KD is detectable in the maternal circulation by 
radioimmunoassay (RIA) from 6 weeks gestation. There 
is a correlation between hCG and hPL levels in ectopic 
pregnancy, which is not surprising as this hormone is 
merely one of a number of substances produced by the 
fetoplacental unit. The predictive value of hPL in sus­
pected ectopic pregnancy is limited as hPL values are 
more frequently normal than the levels of hCG or SP1 
(26). 
ALPHAFETOPROTEIN (AFP) 
Maternal serum alphafetoprotein (AFP) levels have been 
measured in 44 women withhistologically proven ectopic 
pregnancy (39). As expected, highest levels were ob­
served in five women in whom a live fetus was seen 
ultrasonically pre-operatively, supporting the view that 
the fetus is the primary source of maternal AFP. The 
overlap in levels between failed intrauterine pregnancy 
and ectopic pregnancy renders these observations of 
little clinical value. 
OVARIAN STEROIDS 
The activity of the corpus luteum as reflected in proges­
terone levels is receiving greater attention in the diagno­
sis ofectopic pregnancy. Early studies showed depressed 
progesterone levels in up to two-thirds of patients with 
ectopic pregnancy (40-42). Matthews and colleagues 
(43) have reported the use of the rapid determination of 
progesterone levels (within 2 to 4 hours) as an adjunct to 
clinical diagnosis. They have suggested that in the pa­
tient with supporting history and physical signs ofectopic 
pregnancy, a depressed progesterone level «15 ng/ml) 
makes the diagnosis of an accident of pregnancy more 
likely. The predictive value positive of a progesterone 
level> 15 ng/l at less than 8 weeks gestation for a normal 
outcome of that pregnancy reaches 95 per cent. The 
clinical value of these observations remains uncertain, 
and the results ofprospective studies of the specificity of 
depressed progesterone levels for ectopic pregnancy are 
awaited. By comparing progesterone levels in normal 
and ectopic pregnancies with similar hCG levels, 
Hubinont and colleagues (44) have shown that the luteal 
insufficiency observed in ectopic pregnancy cannot be 
explained solely by the decrease of hCG. Furthermore, 
Lower and colleagues (45) have confirmed these find­
ings, notably in women who have ovulated spontane­
ously in the asymptomatic phase, at the time when 
pregnancy was first diagnosed and selecting women 
only if hCG levels were rising. Nevertheless, low pro­
gesterone levels are known to occur in patients with early 
spontaneous abortion in whom the discrepancy between 
hCG and ovarian steroids also occurs. 
The value of oestradiol estimations in ectopic pregnancy 
has been addressed by a few studies. Depressed levels of 
oestradiol have been reported in ectopic pregnancy (19, 
44). Eighty percent of women with ectopic pregnancy 
had serum oestradiol levels below the 10th centile of the 
normal range in these studies, which we were not able to 
confirm in the women described above (45). The overlap 
between values in intra- and extrauterine pregnancy 
remains the major limitation of the use of this pregnancy 
steroid in the management of suspected ectopic gesta­
tion. 
PREGNANCY PROTEIN 12 
(lGF-BINDING PROTEIN) 
Placental protein 12 (PPI2), a glycoprotein identical to 
the small molecular weight binding protein for insulin­
like growth factor (IGF-BP), is synthesised principally 
by decidual cells in the decidua compacta (46). The rate 
of synthesis ofIGF-bp increased dramatically between 6 
and 12 weeks of pregnancy, reflecting decidualisation of 
the endometrium during this period. Preliminary obser­
vations from our group (47) have suggested that regard­
less of the implantation site outside the uterus, ectopic 
pregnancy is associated with normal IGF-bp levels. 
Thus, the decidual synthesis of this protein is probably 
not dependent on the intimate relationship between 
decidua and trophoblast. 
PREGNANCY PROTEIN 14 (PP14) 
This endometrial protein has a molecular weight of 42 to 
56 KD and is synthesised and secreted by the glandular 
epithelium (48) [synonym: progesterone-dependent 
endometrial protein (PEP)] (49). Trends in blood levels 
throughout pregnancy have shown a remarkable similar­
ity with hCG (49), the highest levels being found in 
amniotic fluid at the end of the first trimester (50). 
Preliminary observations from Denmark and London 
(30,31) have indicated that high circulating PP14 levels 
may be used to distinguish between women with normal 
intrauterine and extrauterine pregnancy. These findings 
have been confirmed by Pedersen et al (51), but further 
studies are necessary to examine this phenomenon in 
more detail. 
CONCLUSIONS 
Protein and hormone synthesis by the trophoblast (hCG, 

SPl, PAPP-A), endometrium (PPI4), and ovary (pro­
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gesterone and oestradiol) is depressed in ectopic gesta­
tion. hCG remains the primary biochemical diagnostic 
test used in the clinically stable woman suspected of 
harbouring an ectopic pregnancy. Nevertheless, the cli­
nician should be armed with detailed knowledge of the 
limitations of the assay techniques available. In particu­
lar, negative serum hCG levels should not be equated 
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